Aphakia
56
2
5
40
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
25 trials with published results (45%)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
3.6%
2 terminated out of 56 trials
95.2%
+8.7% vs benchmark
7%
4 trials in Phase 3/4
63%
25 of 40 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 40 completed trials
Clinical Trials (56)
Post Market Clinical Evaluation of Clareon PanOptix Pro and Clareon PanOptix Pro Toric IOLs
Clareon TruPlus Single-Arm Study
Feasibility Study of an Accommodating IOL Design
Evaluation of Long-term Safety and Performance of PanOptix Trifocal Intraocular Lens (IOL)
Contralateral Claims Study of Clareon Vivity Pro
Evaluation of Clareon Vivity/Vivity Toric
Bicentric Clinical Investigation to Assess Safety and Performance of LuxBoost IOL
Clareon PanOptix Pro vs. Clareon PanOptix - Study B
Clareon PanOptix Pro vs. Clareon PanOptix - Study A
Clareon Toric Study (T2-T9)
Evaluation of AcrySof IQ Vivity Extended Vision Intraocular Lenses
A Real-World Evidence (RWE) Long-Term Follow-Up Study to Assess Outcomes of Alcon Monofocal Intraocular Lenses
Post Market Clinical Follow-up (PMCF) Study of Clareon Vivity & Clareon PanOptix
RxSight Light Adjustable Lens and Light Delivery Device New Enrollment Study
Single Center Exploratory Study To Evaluate The Use Of The RxSight Light Adjustable Lens (LAL) And The Light Delivery Device (LDD) To Improve Visual Outcomes
A Clinical Study to Evaluate The Safety and Effectiveness of The RxSight Light Adjustable Lens (LAL) In Subjects Desiring an Extended Depth of Focus
Clareon Toric vs Eyhance Toric
Artisan Aphakia Lens for the Correction of Aphakia in Children
Artisan Aphakia Lens for the Correction of Aphakia (Secondary) in Adults
Registry Study on Intraocular Lenses Manufactured by Teleon Surgical B.V.